$VICR

VINCIARELLI PATRIZIO sold $860K of VICR

VINCIARELLI PATRIZIO (Chairman and CEO) sold 2,762 shares of VICOR CORP (VICR) at $311.53 ($0.86M total) on 2026-06-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jun 5, 2026, 4:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 4:21 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The CEO/Chairman sold 2,762 shares at ~$311.53/share for ~$860.4K; the sale was executed under a pre-arranged Rule 10b5-1 plan.

02

Market read

Routine insider selling disclosure with limited incremental information due to 10b5-1 pre-arrangement.

03

What to watch

The transaction size and the 10b5-1 structure matter; without additional context (e.g., repeated sales, option exercises), the signal is weak.

Relevance 6/10Novelty 3/10Timing: Filed today; sale executed 2026-06-04.

Background

This is an SEC Form 4 insider transaction disclosure for Vicor Corporation (VICR).

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR CEO/Chairman sold $860K of VICR shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited immediate price impact; any effect should be small and short-lived.

Evidence & confidence

The filing is a routine Form 4 insider sale with stated 10b5-1 pre-arrangement, providing less directional information than discretionary selling.

Market effects

No clear sector read-through; this is company-specific insider liquidity/positioning.

None.

None.

Counterpoint

If the market interprets insider sales as confidence erosion, VICR could see short-term sentiment pressure despite the 10b5-1 label.

Key entities

  • VICR

    Vicor Corporation; subject of the insider transaction disclosure.

  • VINCIARELLI PATRIZIO

    Chairman and CEO; reported open-market sale under a 10b5-1 plan.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: